Skip to main content

Table 1 Plasma osmolality, RBC indices and circulating concentrations of analysed metabolites and hormones

From: Administration of glycerol-based formulations in sheep results in similar ovulation rate to eCG but red blood cell indices may be affected

Group

Day

OSMOL/kg

MCV

MCH

MCHC

 

RDW-Sd

GLUCOSE

UREA

 

NEFA

 

INSULIN

GLYCEROL

 
   

(fL)

(pg)

(g/L)

 

(fL)

mg/dL

mg/dL

 

Mmol/L

 

μg/L

mg/dL

 

M100

D0

0.317 ± 0.002

34.50 ± 0.78

11.24 ± 0.27

313.00 ± 2.93

a

28.48 ± 0.78

55.94 ± 3.52

21.65 ± 2.20

a

0.14 ± 0.01

a

0.28 ± 0.06

0.09 ± 0.03

 

M100

D3

0.316 ± 0.001

34.36 ± 0.78

11.12 ± 0.23

324.40 ± 2.56

28.32 ± 0.84

63.96 ± 4.59

13.92 ± 2.10

0.06 ± 0.01

0.40 ± 0.07

0.05 ± 0.00

 

G100

D0

0.317 ± 0.003

36.22 ± 0.91

11.40 ± 0.27

314.80 ± 2.65

 

30.60 ± 0.70

49.42 ± 1.25

24.10 ± 2.58

a

0.11 ± 0.05

 

0.50 ± 0.05

0.14 ± 0.04

 

G100

D3

0.318 ± 0.005

36.02 ± 0.86

11.50 ± 0.29

319.60 ± 6.04

 

30.34 ± 0.61

55.23 ± 2.59

12.38 ± 1.45

0.05 ± 0.02

 

0.66 ± 0.11

0.13 ± 0.05

 

M75

D0

0.275 ± 0.035

35.88 ± 1.32

11.30 ± 0.30

303.60 ± 5.00

 

31.22 ± 1.18

52.63 ± 3.73

25.58 ± 1.75

a

0.18 ± 0.08

 

0.52 ± 0.04

0.20 ± 0.08

 

M75

D3

0.315 ± 0.003

37.24 ± 1.11

11.36 ± 0.29

304.80 ± 6.26

 

30.62 ± 1.20

59.30 ± 2.47

12.87 ± 0.80

0.02 ± 0.00

 

0.70 ± 0.19

0.19 ± 0.12

 

G75

D0

0.308 ± 0.004

33.44 ± 1.11

10.48 ± 0.33

311.20 ± 2.78

 

28.06 ± 1.07

52.28 ± 1.36

22.07 ± 0.61

a

0.31 ± 0.05

a

0.56 ± 0.11

0.16 ± 0.04

 

G75

D3

0.309 ± 0.003

33.44 ± 1.11

10.42 ± 0.34

311.40 ± 2.87

 

27.96 ± 1.01

53.23 ± 4.19

10.95 ± 1.38

0.04 ± 0.01

0.72 ± 0.18

0.17 ± 0.07

 

M50

D0

0.300 ± 0.000

35.84 ± 1.32

11.44 ± 0.25

305.60 ± 6.65

 

31.44 ± 1.34

52.16 ± 2.21

26.80 ± 2.08

a

0.15 ± 0.05

a

0.32 ± 0.08

0.23 ± 0.07

a

M50

D3

0.302 ± 0.001

37.32 ± 1.09

11.44 ± 0.29

307.00 ± 5.43

 

31.42 ± 1.29

57.56 ± 1.13

17.06 ± 1.38

0.03 ± 0.01

0.40 ± 0.09

0.10 ± 0.03

G50

D0

0.311 ± 0.007

33.58 ± 0.85

10.48 ± 0.32

312.00 ± 2.35

 

27.50 ± 0.99

42.43 ± 7.01

29.19 ± 2.02

a

0.12 ± 0.02

 

0.47 ± 0.12

0.38 ± 0.08

 

G50

D3

0.304 ± 0.016

33.34 ± 0.80

10.36 ± 0.30

310.60 ± 2.82

 

27.76 ± 0.98

53.33 ± 2.36

18.32 ± 1.22

0.05 ± 0.03

 

0.50 ± 0.16

0.17 ± 0.06

 

M25

D0

0.311 ± 0.003

34.66 ± 0.88

10.86 ± 0.22

313.00 ± 2.93

 

29.24 ± 1.01

55.94 ± 3.52

21.65 ± 2.20

 

0.23 ± 0.06

 

0.27 ± 0.06

0.12 ± 0.07

 

M25

D3

0.317 ± 0.004

34.70 ± 0.84

11.02 ± 0.28

318.20 ± 2.52

 

29.34 ± 0.99

46.19 ± 3.52

16.54 ± 2.59

 

0.18 ± 0.03

 

0.33 ± 0.08

0.06 ± 0.02

 

G25

D0

0.307 ± 0.001

36.50 ± 0.82

11.36 ± 0.20

311.80 ± 3.40

 

29.96 ± 1.01

48.26 ± 2.03

24.10 ± 2.58

 

0.25 ± 0.08

a

0.32 ± 0.11

0.10 ± 0.05

 

G25

D3

0.306 ± 0.002

36.76 ± 0.87

11.36 ± 0.18

309.60 ± 3.61

 

30.50 ± 1.13

50.44 ± 2.74

20.28 ± 3.04

 

0.04 ± 0.01

0.33 ± 0.08

0.28 ± 0.18

 
  1. aLetters indicate significant differences between D 0 and D 3 (before glycerol-based formulation administration) within the same group; p < 0.05